Bolus fibrinolysis: risk, benefit, and opportunities.
Publication
, Journal Article
Armstrong, PW; Granger, C; Van de Werf, F
Published in: Circulation
February 27, 2001
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
February 27, 2001
Volume
103
Issue
8
Start / End Page
1171 / 1173
Location
United States
Related Subject Headings
- Risk Assessment
- Odds Ratio
- Intracranial Hemorrhages
- Injections, Intravenous
- Humans
- Fibrinolytic Agents
- Fibrinolysis
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., Granger, C., & Van de Werf, F. (2001). Bolus fibrinolysis: risk, benefit, and opportunities. Circulation, 103(8), 1171–1173. https://doi.org/10.1161/01.cir.103.8.1171
Armstrong, P. W., C. Granger, and F. Van de Werf. “Bolus fibrinolysis: risk, benefit, and opportunities.” Circulation 103, no. 8 (February 27, 2001): 1171–73. https://doi.org/10.1161/01.cir.103.8.1171.
Armstrong PW, Granger C, Van de Werf F. Bolus fibrinolysis: risk, benefit, and opportunities. Circulation. 2001 Feb 27;103(8):1171–3.
Armstrong, P. W., et al. “Bolus fibrinolysis: risk, benefit, and opportunities.” Circulation, vol. 103, no. 8, Feb. 2001, pp. 1171–73. Pubmed, doi:10.1161/01.cir.103.8.1171.
Armstrong PW, Granger C, Van de Werf F. Bolus fibrinolysis: risk, benefit, and opportunities. Circulation. 2001 Feb 27;103(8):1171–1173.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
February 27, 2001
Volume
103
Issue
8
Start / End Page
1171 / 1173
Location
United States
Related Subject Headings
- Risk Assessment
- Odds Ratio
- Intracranial Hemorrhages
- Injections, Intravenous
- Humans
- Fibrinolytic Agents
- Fibrinolysis
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 4207 Sports science and exercise